日本のデジタルヘルス市場 (2025年～2033年)

日本のデジタルヘルス市場は、2024年に109億6,000万米ドルに達し、2033年には5,142万米ドルに達し、2025年から2033年の予測期間中にCAGR 19.0％で成長すると予測されています。

デジタルヘルスとは、デジタル技術を利用して医療の提供を改善し、健康成果を高め、患者の全体的な幸福を促進することを指します。この急成長分野は、モバイルアプリ、ウェアラブル、人工知能（AI）、遠隔医療、電子カルテ（EHR）などの技術を医療のさまざまな側面に統合します。その目的は、ケアの効率性、アクセシビリティ、質を向上させ、医療サービスをより個別化し、タイムリーで効果的なものにすることです。

デジタルヘルス・ソリューションは、様々な医療提供者間のより良いケアの連携を促進し、患者の体験を改善し、断片的なケアを減らします。技術が進化を続ける中、デジタルヘルスは医療の提供方法をさらに変革し、よりアクセスしやすく、効率的で、患者中心のサービスを提供することが期待されています。

市場力学：

促進要因と抑制要因

老年人口の増加

日本の高齢化はデジタルヘルス市場の主要促進要因であり、慢性疾患の有病率の上昇や長期介護の必要性から医療サービスに対する需要が増加しています。遠隔医療、遠隔モニタリング、ウェアラブル、AI駆動ツールなどのデジタルヘルス・ソリューションは、高齢者が遠隔でケアにアクセスし、重要な健康指標をリアルタイムで追跡し、慢性疾患をより効果的に管理できるようにすることで、こうした課題に対処する上で不可欠です。

これらのテクノロジーは、個別化されたケアを提供するだけでなく、特に専門家が不足している地方では、医療提供者の負担を軽減します。さらに、支援ロボットやスマートホーム・ソリューションのようなイノベーションは、高齢者の日常生活を向上させています。「医療政策2025」のようなイニシアチブを通じた政府の支援により、デジタルヘルス・ソリューションは日本の医療制度にますます統合されつつあり、高齢者が必要なケアを受けられるようにすると同時に、医療全体の効率とアクセシビリティを向上させています。

技術的限界

技術的な限界は、いくつかの点で日本のデジタルヘルス市場の成長を大きく妨げると予想されます。日本には強力な技術インフラがあるにもかかわらず、医療システム間の相互運用性が不十分であること、ソフトウェアが旧式であること、データ・フォーマットが標準化されていないことなどの課題が、デジタルヘルス・ソリューションのシームレスな統合を制限する可能性があります。

目次

第1章 分析手法と分析範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 高齢化人口の増加
    • 在宅医療における先進技術の導入増加
  • 抑制要因
    • 技術的な制限
    • データプライバシーに関する懸念
  • 機会
    • 市場参入企業による戦略的取り組みの増加
• 影響分析

第5章 戦略的洞察と業界展望

• 市場のリーダーと先駆者
  • 新たな先駆者と主要企業
  • 最大の売上を誇るブランドを確立したリーダー
  • 確立された製品を持つ市場リーダー
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の研究
• 規制と償還の情勢
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析：ベストケース・ベースケース・ワーストケースの予測
• 価格分析と価格市場力学
• キーオピニオンリーダー (KOL)

第6章 コンポーネント別

• ハードウェア
• ソフトウェア
• サービス

第7章 種類別

• mヘルス
• eヘルス
• テレヘルス（遠隔医療）
• 健康分析
• その他

第8章 エンドユーザー別

• 医療提供者
• 医療消費者
• その他

第9章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第10章 企業プロファイル

• OMRON Corporation
  • 企業概要
  • 製品ポートフォリオ
    • 製品説明
    • 製品の主要業績評価指標（KPI）
    • 製品販売の実績・予測
  • 財務概要
    • 企業の収益
    • 収益シェア：地域別
    • 収益予測
  • 主な動向
    • 企業合併・買収 (M&A)
    • 主な製品開発活動
    • 規制当局の承認等
  • SWOT分析
• CureApp
• Shionogi & Co., Ltd.
• HealthNode
• Whill
• Allm Inc.
• Dai-ichi Life Holdings, Inc.
• Xiaomi
• Hitachi Energy Ltd.
• Similar data will be provided for each market player.

第11章 付録

The Japan digital health market reached US$ 10.96 billion in 2024 and is expected to reach US$ 51.42 million by 2033, growing at a CAGR of 19.0% during the forecast period of 2025-2033.

Digital health refers to using digital technologies to improve healthcare delivery, enhance health outcomes, and promote a patient's overall well-being. This rapidly growing field integrates technology such as mobile apps, wearables, artificial intelligence (AI), telemedicine, and electronic health records (EHRs) into various aspects of healthcare. The objective is to enhance the efficiency, accessibility, and quality of care, making healthcare services more personalized, timely, and effective.

Digital health solutions facilitate better coordination of care across various healthcare providers, improving patient experiences and reducing fragmented care. As technology continues to evolve, digital health is expected to further revolutionize how healthcare is delivered, offering more accessible, efficient, and patient-centered services.

Market Dynamics: Drivers & Restraints

Rising Geriatric Population

Japan's aging population is a key driver of the digital health market, as the demand for healthcare services increases due to the higher prevalence of chronic diseases and the need for long-term care. Digital health solutions, such as telemedicine, remote monitoring, wearables, and AI-driven tools, are essential in addressing these challenges by enabling elderly individuals to access care remotely, track vital health metrics in real time, and manage chronic conditions more effectively.

These technologies not only provide personalized care but also reduce the burden on healthcare providers, particularly in rural areas where there is a shortage of professionals. Additionally, innovations like assistive robots and smart home solutions are improving the daily lives of elderly people. With government support through initiatives like the "Healthcare Policy 2025," digital health solutions are increasingly integrated into Japan's healthcare system, ensuring that elderly citizens can receive the care they need while improving overall healthcare efficiency and accessibility.

Technical Limitations

Technical limitations are expected to significantly hinder the growth of Japan's digital health market in several ways. Despite Japan's strong technological infrastructure, challenges such as insufficient interoperability between healthcare systems, outdated software, and lack of standardized data formats can limit the seamless integration of digital health solutions.

Segment Analysis

The Japan digital health market is segmented based on component, type, and end-user.

Type:

mHealth in the type segment is expected to dominate in the Japan digital health market.

Japan has a high smartphone penetration rate and a tech-savvy population, making mobile health applications and services highly accessible and widely adopted. The aging population, in particular, is a major driver for mHealth solutions, as mobile apps and wearables can help older adults monitor their health, track vital signs, and manage chronic conditions without requiring frequent visits to healthcare providers.

mHealth solutions, such as health tracking apps, medication reminders, and telemedicine platforms, offer convenience and flexibility for patients, empowering them to take charge of their health. Moreover, Japan's focus on preventative care and wellness aligns with the growing use of mHealth tools that promote healthier lifestyles, encourage regular physical activity, and track diet and sleep. As more healthcare providers and patients embrace mobile solutions for daily health management, the mHealth segment is expected to lead Japan's digital health market growth by offering efficient, accessible, and personalized healthcare options.

Competitive Landscape

The major players in Japan digital health market include Takeda Pharmaceutical Company Limited, OMRON Corporation, CureApp, Shionogi & Co., Ltd., HealthNode, Whill, Allm Inc., Dai-ichi Life Holdings, Inc., Xiaomi, and Hitachi Energy Ltd., among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Digital Health Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Component
• 3.2. Snippet by Type
• 3.3. Snippet by End-User

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising Geriatric Population
    • 4.1.1.2. Increasing Adoption of Advanced Technologies in Home Healthcare
  • 4.1.2. Restraints
    • 4.1.2.1. Technical Limitations
    • 4.1.2.2. Data Privacy Concerns
  • 4.1.3. Opportunity
    • 4.1.3.1. Increasing Strategic Initiatives by Market Players
• 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

• 5.1. Market Leaders and Pioneers
  • 5.1.1. Emerging Pioneers and Prominent Players
  • 5.1.2. Established leaders with largest selling Brand
  • 5.1.3. Market leaders with established Product
• 5.2. CXO Perspectives
• 5.3. Latest Developments and Breakthroughs
• 5.4. Case Studies/Ongoing Research
• 5.5. Regulatory and Reimbursement Landscape
• 5.6. Porter's Five Forces Analysis
• 5.7. Supply Chain Analysis
• 5.8. Patent Analysis
• 5.9. SWOT Analysis
• 5.10. Unmet Needs and Gaps
• 5.11. Recommended Strategies for Market Entry and Expansion
• 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 5.13. Pricing Analysis and Price Dynamics
• 5.14. Key Opinion Leaders

6. By Component

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Component
  • 6.1.2. Market Attractiveness Index, By Component
• 6.2. Hardware*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Software
• 6.4. Services

7. By Type

• 7.1. Introduction
  • 7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. mHealth*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. eHealth
• 7.4. Telehealthcare
• 7.5. Health Analytics
• 7.6. Others

8. By End-User

• 8.1. Introduction
  • 8.1.1. Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 8.1.2. Market Attractiveness Index, By End-User
• 8.2. Healthcare Providers*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Healthcare Consumers
• 8.4. Others

9. Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

• 10.1. OMRON Corporation*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue's
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals, etc.
  • 10.1.5. SWOT Analysis
• 10.2. CureApp
• 10.3. Shionogi & Co., Ltd.
• 10.4. HealthNode
• 10.5. Whill
• 10.6. Allm Inc.
• 10.7. Dai-ichi Life Holdings, Inc.
• 10.8. Xiaomi
• 10.9. Hitachi Energy Ltd.
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us